FDA Approval for Lead Drug Candidate
Resolves: The company receives regulatory approval for its lead drug candidate.
sec_filing· REGULATORY
FDA Approval for Lead Drug Candidate
Market overview
Derived from Camp4 Therapeutics Corp (CAMP) (CIK 0001736730) 8-K filing analysis
REGULATORY prediction market
- Implied probability (Yes)
- 55%
- Closes
- 2027-06-28
About this prediction
Resolution criteria
The company receives regulatory approval for its lead drug candidate.
More REGULATORY markets
- Crypto billionaire Harborne faces FCA scrutiny over £5m gift — 55% Yes
- Crypto billionaire Harborne will face FCA scrutiny — 60% Yes
- Crypto billionaire Christopher Harborne’s donation triggers FCA inquiry into funding transparency — 70% Yes
- Crypto billionaire Christopher Harborne will face parliamentary scrutiny over £5m gift — 55% Yes
- Harborne crypto holdings face regulatory scrutiny — 60% Yes
- SEC approves at least 2 new Bitcoin ETFs by Q4 2027 — 75% Yes
- SEC approves Kalshi's crypto futures products by 2026-Q3 — 55% Yes
- Iran's central bank bans crypto mining by 2027 Q1 — 85% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…